Replies to post #7701 on Relief Therapeutics Holding AG (RLFTF)

[maximumgriff]

Say what? You mean the FDA is wrong?

Aviptadil is a formulation of Vasoactive Intestinal Polypeptide (VIP), which is present in high concentrations in the lungs and known to block various inflammatory cytokines. NeuroRx and Relief partnered to develop the drug in Covid-19 indication.

The drug candidate secured fast track designation from the US Food and Drug Administration (FDA) to treat respiratory distress associated with Covid-19.

[mikar]

It’s a DRUG! Please stop saying it’s NOT A DRUG!!

[Andy2018]

Go talk to FDA. They assigned Fast Track and priority review. This is the only Fast Track therapy drug in the world. It’s CURE. $RLFTF